Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Transplantation of mesenchymal stem cells in a laryngeal carcinoma patient with radiation myelitis.
Youth and environmental enrichment generate serum exosomes containing miR-219 that promote CNS myelination.
Prefrontal tDCS Decreases Pain in Patients with Multiple Sclerosis.
Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.
Effects of Eight-week Resistance Training Program in Men With Multiple Sclerosis.
The relationship between the rate of brain volume loss during first 24 months and disability progression over 24 and 48 months in relapsing MS.
Impact of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod: Subgroup analyses of the Fingolimod Research Evaluating Effects of Daily Oral Therapy in Multiple Sclerosis (FREEDOMS) study.
The use of laboratory gait analysis for understanding gait deterioration in people with multiple sclerosis.
Increased Concentrations of Interleukin-33 in the Serum and Cerebrospinal Fluid of Patients with Multiple Sclerosis.
Nerve ultrasound protocol in differentiating chronic immune-mediated neuropathies.
Natalizumab-induced POU2AF1/Spi-B upregulation: A possible route for PML development.
Comparison of Patients With Relapsing Remitting Multiple Sclerosis (Rrms) Treated With Disease Modifying Treatments (Dmt) In Europe (Eu) And The United States (Us).
[Target Molecule for a Demyelinating Type of Guillain-Barré Syndrome, Acute Inflammatory Demyelinating Polyneuropathy].
How Fatigue Influences Exercise Participation in Men With Multiple Sclerosis.
Clinical and epidemiological profiles of non-traumatic myelopathies.
T-cell responses to distinct AQP4 peptides in patients with neuromyelitis optica (NMO).
Regulation of oligodendrocyte precursor maintenance by chondroitin sulphate glycosaminoglycans.
Survey of Neurologist's Current Practices in Evaluation of Multiple Sclerosis to Identify Domains for a New Clinician-Reported Measure.
Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
Cost-Utility Analysis of Natalizumab as First-Line Treatment of Highly-Active Relapsing-Remitting Multiple Sclerosis in the Brazilian Public Healthcare System.
Fingolimod Real World Experience: Efficacy and Safety in Clinical Practice.
Autoantibodies to tetraspanins (CD9, CD81 and CD82) in demyelinating diseases.
Demyelinating diseases in Asia.
Acute demyelinating disorders of the central nervous system.
Neurosarcoidosis: Clinical Features, Diagnosis, and Management.

Pages